Regulatory
Homeopathic Product Statistics in FDA’s Office of Pharmaceutical Quality Annual Report
The Federal Trade Commission recently published rules regarding consumer endorsements and testimonials which take effect in less than two months. The rules are wide ranging and cover: relationships , compensation, prohibitions, misrepresentation or far more. Violators will be fined under the new rules. The AAHP has prepared a brief overview of …
Read MoreAllied Organization: HOHM Research
The Federal Trade Commission recently published rules regarding consumer endorsements and testimonials which take effect in less than two months. The rules are wide ranging and cover: relationships , compensation, prohibitions, misrepresentation or far more. Violators will be fined under the new rules. The AAHP has prepared a brief overview of …
Read MoreNew Peer-Reviewed Published Study on the Status of Homeopathy Taught in U.S. Pharmacy Schools
The Federal Trade Commission recently published rules regarding consumer endorsements and testimonials which take effect in less than two months. The rules are wide ranging and cover: relationships , compensation, prohibitions, misrepresentation or far more. Violators will be fined under the new rules. The AAHP has prepared a brief overview of …
Read MoreFTC Issues Rule to Crack Down on Fake Consumer Reviews
The Federal Trade Commission recently published rules regarding consumer endorsements and testimonials which take effect in less than two months. The rules are wide ranging and cover: relationships , compensation, prohibitions, misrepresentation or far more. Violators will be fined under the new rules. The AAHP has prepared a brief overview of …
Read MoreFDA Issues FY23 Drug Safety Priorities Report
In February 2024, FDA’s Center for Drug Evaluation and Research (CDER) published its ninth yearly report describing key safety programs and activities, and illustrating the depth and versatility of drug…
Read MoreFDA Guidance Document Development Process
By Alvin J. Lorman, AAHP Counsel The Food and Drug Administration (FDA) is seeking public comment on a draft “Report and Plan on Best Practices for Guidance.” Guidance documents, rather…
Read More118th Congress: Legislative Productivity Stymied by Partisan Divide
The 2022 midterm election resulted in putting Republicans in control of the House of Representatives by the narrowest of margins (222 to 213). With the Democrats succeeding in maintaining control…
Read MoreThe History and Future of Regulations for Homeopathy
The principal federal regulators of the manufacture, sale, and marketing of homeopathic drug products are the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC). Both agencies recognize…
Read MoreIncreased FDA Scrutiny of Eye Care Category
By Alvin J. Lorman, AAHP Counsel The Food and Drug Administration (FDA) last week continued its heightened surveillance on ophthalmic drug products sold without FDA approval or without complying with…
Read MoreFTC Proposes Rule Against False or Misleading Consumer Reviews and Testimonials
By Alvin J. Lorman, AAHP Counsel The Federal Trade Commission (FTC) has announced that it is moving forward with a proposed Trade Regulation Rule that is intended to prevent fake,…
Read More